Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy. - Wikidata - awgldk - TriplyDB

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q37867324

about

The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk.Hypertrophic cardiomyopathy: a review The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy Polymorphisms in the canine and feline renin-angiotensin-aldosterone system genes.Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk: A systematic review and meta-analysis.Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.

P2860

Q27002339-616701B6-DA94-4921-998B-DC991241EB6B Q34730199-BA46B4EE-E8E9-48F4-9C97-D6915B13364D Q35024040-CA7DA7EB-DD4B-43FB-A207-631989B890A7 Q36253420-053AF9DA-7F15-4460-B849-9B58093AF58E Q44856043-82BD701C-1B34-42D7-9D62-5D29B6F42D49 Q47196704-7E78E0C3-E0A2-4A8E-B284-27F22280E2AB Q53269159-4A800B21-7D71-4097-8E67-E363383E7B91

P2860

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q37867324

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@en

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@nl

type

label

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@en

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@nl

prefLabel

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@en

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@nl

P1433

Q37867324-24374B3D-E7C0-4BA5-976E-5E4490371580

P1476

Q37867324-5A837248-02DE-4C0E-8CF3-FE941802C3A5

P2093

Q37867324-147039E4-EDB0-4E72-BD85-54046AF38CBF

Q37867324-36A27706-9FDA-4AE3-9FBB-810D5F482ECF

Q37867324-46670CC2-4256-450A-838D-93E44BBF314C

Q37867324-CB4D3429-7BEE-46E3-895C-8480BC9F1255

Q37867324-DC4E99C4-EB0E-4C68-B319-2F277710CFDD

P2860

Q37867324-002443C8-1E3B-4728-B44C-E052A4D52BBA

Q37867324-10BC8974-31E0-41A2-8AB2-87B0143270E6

Q37867324-10F65F13-FF35-4FDD-BA2E-715C9F145230

Q37867324-16AD3B0C-C8E0-4BD6-B04C-E42FD9945DBA

Q37867324-1775C72B-525A-4EE9-B537-9AEE965ADA04

Q37867324-18EBED8E-F2D2-4F2A-992E-43F6B2DE9B4B

Q37867324-1E78084B-74F3-44BD-B9F5-BD3F2CCDCA83

Q37867324-1E93A5DE-4475-4DDC-B770-5A1ED784AA81

Q37867324-226BD9B5-A4D8-403E-9A8E-0B979087421D

Q37867324-309B32AE-AC80-460F-8923-A1858E6F667C

P304

Q37867324-22128B3D-7FE6-4733-B74D-8CAE4E4943C9

P31

Q37867324-3a5a7607-ed26-427b-8359-ec51f3195523

Q37867324-CE8140FC-DBB6-4038-8AD7-D9191D592764

P356

Q37867324-EAC30EF0-5976-4D00-847B-106AAE63E0CC

P433

Q37867324-BC6A2970-B9E0-4152-BF77-144A7CFCACF8

P478

Q37867324-BD444E28-0FE8-4DE3-BA44-67374F24A777

P50

Q37867324-269DB03F-3A20-4B17-A06F-A1B25747AC83

P577

Q37867324-3FDD94F4-91AB-4EDF-AEB1-D4BA9670053C

P5875

Q37867324-AC0277FF-B22C-422D-A158-814A66413F11

P698

Q37867324-D41D9CD5-495C-4FFD-BF49-5A7E4386EDA5

P356

1470320311405247

P1433

Journal of the Renin-Angiotensin-Aldosterone System

P1476

Impact of polymorphisms in the ...... n hypertrophic cardiomyopathy.

@en

P2093

Diana Hernández-Romero

http://www.w3.org/2001/XMLSchema#string

Esteban Orenes-Piñero

http://www.w3.org/2001/XMLSchema#string

Eva Jover

http://www.w3.org/2001/XMLSchema#string

Francisco Marín

http://www.w3.org/2001/XMLSchema#string

Mariano Valdés

http://www.w3.org/2001/XMLSchema#string

P2860

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy

Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes

The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex

A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy

Familial hypertrophic cardiomyopathy: from mutations to functional defects

Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis.

Hypertrophic cardiomyopathy: from genetics to treatment

P304

521-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1470320311405247

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Y. H. Lip

P577

2011-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51065376

http://www.w3.org/2001/XMLSchema#string

P698

21507890

http://www.w3.org/2001/XMLSchema#string